Cargando…

Immune Aging and Immunotherapy in Cancer

Immune functions decline as we age, while the incidence of cancer rises. The advent of immune checkpoint blockade (ICB) has not only revolutionized cancer therapy, but also spawned great interest in identifying predictive biomarkers, since only one third of patients show treatment response. The agin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaiser, Melanie, Semeraro, Maria Donatella, Herrmann, Markus, Absenger, Gudrun, Gerger, Armin, Renner, Wilfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269421/ https://www.ncbi.nlm.nih.gov/pubmed/34209842 http://dx.doi.org/10.3390/ijms22137016

Ejemplares similares

Telomeres and Age-Related Diseases
por: Gruber, Hans-Jürgen, et al.
Publicado: (2021)

Haptoglobin polymorphism and prostate cancer mortality
por: Kaiser, Melanie, et al.
Publicado: (2020)

Influences of Long-Term Exercise and High-Fat Diet on Age-Related Telomere Shortening in Rats
por: Semeraro, Maria Donatella, et al.
Publicado: (2022)

Telomere length in leucocytes and solid tissues of young and aged rats
por: Semeraro, M. Donatella, et al.
Publicado: (2022)

Physical activity, a modulator of aging through effects on telomere biology
por: Semeraro, Maria Donatella, et al.
Publicado: (2020)

The impact of moderate endurance exercise on cardiac telomeres and cardiovascular remodeling in obese rats
por: Semeraro, Maria Donatella, et al.
Publicado: (2023)

ASCO update: lung cancer
por: Absenger, Gudrun, et al.
Publicado: (2017)

Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study
por: Barth, Dominik A., et al.
Publicado: (2022)

The effects of long-term moderate exercise and Western-type diet on oxidative/nitrosative stress, serum lipids and cytokines in female Sprague Dawley rats
por: Semeraro, Maria Donatella, et al.
Publicado: (2021)

Cancer Immunotherapy and the Immune Response in Follicular Lymphoma
por: Stenner, Frank, et al.
Publicado: (2018)

Cancer Immunotherapy and the Immune Response in Hodgkin Lymphoma
por: Renner, Christoph, et al.
Publicado: (2018)

A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival
por: Hofmann, Guenter, et al.
Publicado: (2009)

External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
por: Szkandera, Joanna, et al.
Publicado: (2013)

Current Status of Long Non-Coding RNAs in Human Cancer with Specific Focus on Colorectal Cancer
por: Smolle, Maria, et al.
Publicado: (2014)

Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study
por: Barth, Dominik A., et al.
Publicado: (2022)

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study
por: Riedl, Jakob M., et al.
Publicado: (2020)

Hedgehog Signaling Pathway in Ovarian Cancer
por: Szkandera, Joanna, et al.
Publicado: (2013)

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
por: Stotz, M, et al.
Publicado: (2014)

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
por: Absenger, G, et al.
Publicado: (2013)

Immunotherapy and Immune Evasion in Prostate Cancer
por: Thakur, Archana, et al.
Publicado: (2013)

The Liver–Immunity Nexus and Cancer Immunotherapy
por: Lee, James C., et al.
Publicado: (2022)

Exploiting innate immunity for cancer immunotherapy
por: Yi, Ming, et al.
Publicado: (2023)

Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer
por: Silvestri, Ida, et al.
Publicado: (2015)

Immunotherapy in Gastric Cancer
por: Högner, Anica, et al.
Publicado: (2022)

HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
por: Papaccio, Federica, et al.
Publicado: (2018)

The Erythropoetin rs1617640 Gene Polymorphism Associates with Hemoglobin Levels, Hematocrit and Red Blood Cell Count in Patients with Peripheral Arterial Disease
por: Renner, Wilfried, et al.
Publicado: (2020)

Immune checkpoints and immunotherapy for colorectal cancer
por: Singh, Preet Paul, et al.
Publicado: (2015)

Immune checkpoint signaling and cancer immunotherapy
por: He, Xing, et al.
Publicado: (2020)

Creatine in T Cell Antitumor Immunity and Cancer Immunotherapy
por: Li, Bo, et al.
Publicado: (2021)

MicroRNAs: immune modulators in cancer immunotherapy
por: Xing, Yun, et al.
Publicado: (2021)

Autophagy-associated immune responses and cancer immunotherapy
por: Pan, Hongming, et al.
Publicado: (2016)

Cancer immunotherapy beyond immune checkpoint inhibitors
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018)

The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy
por: Ahmed, Mohamed E., et al.
Publicado: (2020)

Tumor immune response and immunotherapy in gastric cancer
por: Kwak, Yoonjin, et al.
Publicado: (2020)

The Effects of Obesity on Anti-Cancer Immunity and Cancer Immunotherapy
por: Woodall, Matthew J., et al.
Publicado: (2020)

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
por: Xie, Feng, et al.
Publicado: (2019)

Senescence and Aging: Does It Impact Cancer Immunotherapies?
por: Maggiorani, Damien, et al.
Publicado: (2021)

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
por: Brcic, Luka, et al.
Publicado: (2018)

Editorial: Emerging talents in cancer immunity and immunotherapy: 2022
por: Maeurer, Markus
Publicado: (2023)

Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
por: Dai, Enyong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8oo6tatd4uql2i66s8v9bn067h